Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-21-010022
Filing Date
2021-05-12
Accepted
2021-05-12 16:32:25
Documents
1
Period of Report
2021-05-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162085152431857.html 4  
1 FORM 4 wf-form4_162085152431857.xml 4 5410
  Complete submission text file 0001628280-21-010022.txt   6748
Mailing Address ONE MEDIMMUNE WAY GAITHERSBURG MD 20878
Business Address
Greenleaf Peter (Reporting) CIK: 0001363683 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36421 | Film No.: 21915605

Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Issuer) CIK: 0001600620 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations